GSK-F1

GSK-F1
Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-1220-M001 1 mg -

3 - 9 business days*

185.00€
SYN-1220-M005 5 mg -

3 - 9 business days*

385.00€
SYN-1220-M010 10 mg -

3 - 9 business days*

601.00€
SYN-1220-M050 50 mg -

3 - 9 business days*

-
SYN-1220-M100 100 mg -

3 - 9 business days*

-
 
Solid. Soluble in DMSO. GSK-F1 is a potent PI4KA inhibitor. It has better pharmacokinetic... more
Product information "GSK-F1"
Solid. Soluble in DMSO. GSK-F1 is a potent PI4KA inhibitor. It has better pharmacokinetic properties in vivo than to GSK-A1 (SYN-1219). GSK-F1 does not cross the blood-brain barrier. Phosphatidylinositol 4-kinase type III? (PI4KA) is a host factor essential for hepatitis C virus replication and hence is a target for drug development. RNAi studies have shown that PI4KA is a mandatory host factor in HCV replication. Down-regulation of PI4KA appears to be reasonably tolerated by cultured cell models and results.
Keywords: 5-(2-Amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide, GSKF1
Supplier: SYNkinase
Supplier-Nr: 1220

Properties

Application: Potent PI4KA inhibitor
MW: 603,5 D
Formula: C27H18F5N5O4S
Purity: >95%
Format: Solid

Database Information

CAS : 1402345-92-9| Matching products
KEGG ID : K00888 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +20°C)
GHS Hazard Pictograms:
H Phrases: H302, H317, H332
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK-F1"
Write a review
or to review a product.
Viewed